TFAM Expression, rs1937 Variant, and Mitochondrial DNA Copy Number in Egyptian Myocardial Infarction Patients
7 affiliations
- 1Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, Shebin El Kom 32511, Egypt
- 2Department of Basic Medical Sciences, Unaizah College of Medicine and Medical Sciences, Qassim University, Unaizah, 51452, Saudi Arabia
- 3Cardiology Department, Faculty of Medicine, Menoufia University, Shebin El Kom 32511, Egypt
- 4Clinical Pathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom 32511, Egypt
- 5Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Cairo 11956, Egypt
- 6Department of Pathology, College of Medicine, Qassim University, Unaizah,51452, Saudi Arabia
- 7Cardiology Department, Faculty of Medicine, Benha University, Benha, Egypt
Abstract
Myocardial infarction (MI) is a fatal condition that causes damage to the heart muscle by abruptly stopping blood flow and oxygenation. Mitochondrial transcription factor A (TFAM) and mitochondrial DNA copy number (mtDNA CN) show an increased rate of association with development of several human diseases and malignancies. This paper, therefore, aims to identify the possible relation among mtDNA CN and its regulating gene TFAM (expression of the gene and rs1937 polymorphism) as markers in myocardial infarction among Egyptians. A total of 200 participants were enrolled and divided into two groups. Group 1 included 100 myocardial infarction patients with ST-segment elevation (STEMI) recruited from from the Coronary Care Unit (CCU) of Menoufia University Hospitals, while group 2 included 100 Controls. Blood samples were collected from all participants immediately after diagnosis of MI and before beginning therapy. TFAM SNP (rs1937) was determined by the allelic discrimination TaqMan technique, and mtDNA CN and TFAM gene expression were detected using real-time quantitative PCR in 100 MI patients and 100 controls. TFAM mRNA expression and mtDNA copy number were profoundly reduced in MI patients than controls. Analysis of genotype showed that the TFAM rs1937 variant distribution was in Hardy-Weinberg equilibrium. The C allele and the GC genotype were substantially more frequent in the patients’ cohort (p = 0.006 and 0.005, respectively). The GC genotype of the TFAM polymorphism (rs1937) showed a preliminary association with MI in STEMI patients. Limitations of this study are the absence of longitudinal pre-MI or post-recovery data. TFAM mRNA expression and mtDNA copy number were measured in whole blood without adjustment for leukocyte subpopulations or platelet counts. Small number of C carriers of TFAM rs1937 variant and absence of CC genotype limited statistical power and requires replication in larger Egyptian cohort. These findings suggest that decreased TFAM gene expression and mtDNA CN were significant biomarkers associated with acute myocardial infarction in STEMI patients.
Related
- Cardiomyocyte-specific deletion of thioredoxin promotes myocardial injury, infarction and mitochondrial dysfunction: translocation of cytosolic thioredoxin into mitochondria rescue myocardial dysfunction by restoration of cardiac mitochondrial structure and function.
- Myocardial lipid remodeling in patients with myocardial infarction undergoing cardiac surgery
- Metabolomic Analysis of Patients with Coronary Artery Disease and Acute Myocardial Infarction by Using Nuclear Magnetic Resonance Spectroscopy
- The heart-liver axis controls platelet turnover by hepatic STAT3 phosphorylation and TPO regulation after acute myocardial infarction
- Efficacy and safety of bone marrow mononuclear cell therapy for myocardial infarction: a dose–response meta-analysis
BibTeX
@article{naidany2026tfam,
title = {{TFAM Expression, rs1937 Variant, and Mitochondrial DNA Copy Number in Egyptian Myocardial Infarction Patients}},
author = {Sherin Sobhy El naidany and Heba F. Khader and Asmaa Abdelkarim Kenawy and Mohammed G. Elhelbawy and Zahraa Azab Mohamed Abouelatta and Hoda Ahmed Abdelmoneim and Reham Abdulla Aboukhalil and Wael Tawfik and Mai A. H. Abouelenin},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27219617},
url = {https://www.mdpi.com/1422-0067/27/21/9617},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - TFAM Expression, rs1937 Variant, and Mitochondrial DNA Copy Number in Egyptian Myocardial Infarction Patients
AU - Sherin Sobhy El naidany
AU - Heba F. Khader
AU - Asmaa Abdelkarim Kenawy
AU - Mohammed G. Elhelbawy
AU - Zahraa Azab Mohamed Abouelatta
AU - Hoda Ahmed Abdelmoneim
AU - Reham Abdulla Aboukhalil
AU - Wael Tawfik
AU - Mai A. H. Abouelenin
PY - 2026
DA - 2026/10/27
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219617
UR - https://www.mdpi.com/1422-0067/27/21/9617
AB - Myocardial infarction (MI) is a fatal condition that causes damage to the heart muscle by abruptly stopping blood flow and oxygenation. Mitochondrial transcription factor A (TFAM) and mitochondrial DNA copy number (mtDNA CN) show an increased rate of association with development of several human diseases and malignancies. This paper, therefore, aims to identify the possible relation among mtDNA CN and its regulating gene TFAM (expression of the gene and rs1937 polymorphism) as markers in myocardial infarction among Egyptians. A total of 200 participants were enrolled and divided into two groups. Group 1 included 100 myocardial infarction patients with ST-segment elevation (STEMI) recruited from from the Coronary Care Unit (CCU) of Menoufia University Hospitals, while group 2 included 100 Controls. Blood samples were collected from all participants immediately after diagnosis of MI and before beginning therapy. TFAM SNP (rs1937) was determined by the allelic discrimination TaqMan technique, and mtDNA CN and TFAM gene expression were detected using real-time quantitative PCR in 100 MI patients and 100 controls. TFAM mRNA expression and mtDNA copy number were profoundly reduced in MI patients than controls. Analysis of genotype showed that the TFAM rs1937 variant distribution was in Hardy-Weinberg equilibrium. The C allele and the GC genotype were substantially more frequent in the patients’ cohort (p = 0.006 and 0.005, respectively). The GC genotype of the TFAM polymorphism (rs1937) showed a preliminary association with MI in STEMI patients. Limitations of this study are the absence of longitudinal pre-MI or post-recovery data. TFAM mRNA expression and mtDNA copy number were measured in whole blood without adjustment for leukocyte subpopulations or platelet counts. Small number of C carriers of TFAM rs1937 variant and absence of CC genotype limited statistical power and requires replication in larger Egyptian cohort. These findings suggest that decreased TFAM gene expression and mtDNA CN were significant biomarkers associated with acute myocardial infarction in STEMI patients.
SN - 1422-0067
ER -